期刊文献+

体检者血清25(OH)D与非酒精性脂肪肝的相关性分析 被引量:1

Correlation Between the Level of Serum 25(OH)D and Nonalcoholic Fatty Liver Disease in Physical Examinees
下载PDF
导出
摘要 目的探讨25(OH)D在非酒精性脂肪肝(NAFLD)患者中的特点,分析25(OH)D与NAFL D的相关性。方法选取2018年5月至2018年10月于我院体检中心体检者563名纳入本研究。根据有无NAFLD将受试者分为NAFLD组和对照组(NC组)。所有受试者均进行体格检查和生化指标的测定,比较两组间25(OH)D及所有临床代谢指标的差异。应用Spearman相关分析25(OH)D与各代谢指标的相关性,根据25(OH)D水平四分位数将受试者分为4组,比较组间NAFLD发生率的差异。结果NAFLD组BMI、WC、ALT、AST、GGT、FPG、HOMA-IR、SUA、TC、TG、LDL-C、SBP、DBP水平均高于NC组,差异有统计学意义(P<0.01);NAFLD组25(OH)D及HDL-C水平低于NC组,差异有统计学意义(P<0.01)。Spearma n相关分析显示,NAFLD组25(OH)D与FPG(r=-0.221)、TG(r=-0.250)呈负相关(P均<0.01);25(OH)D与NAFLD呈负相关(r=-0.111,P=0.009)。NAFLD发生率随着25(OH)D水平的升高有下降趋势(P<0.01)。结论NAFLD组25(OH)D水平更低,二者之间具有相关性。 Objective To investigate the characteristics of serum 25(OH)D level in patients with nonalcoholic fatty liver disease(NAFLD),and to analyze the correlation between 25(OH)D and NAFLD.Methods A total of 563 physical examinees who visited the Health Examination Centre of Beijing Shijingshan Hospital for annual physical examination from May 2018 to Oct 2018 were enrolled in this study.According to the presence of NAFLD,they were divided into the NAFLD group and the control group(NC group).All subjects were performed the physical examination and biochemical indexes.The differences of serum 25(OH)D and clinical metabolic indicators between the two groups were compared.Spearman correlation analysis was used to analyze the relationship between serum 25(OH)D and various metabolic indexes.According to the quartile of 25(OH)D level,all subjects were divided into four groups and the incidence of NAFLD were compared among groups.Results The levels of BMI,WC,ALT,AST,GGT,FPG,HOMA-IR,SUA,TC,TG,SBP and DBP in NAFLD group were significantly higher than those in the NC group(P<0.01),while the levels of 25(OH)D and HDL-C in the NAFLD group were significantly lower than those in the NC group(P<0.01).Spearman correlation analysis showed that 25(OH)D level in the NAFLD group were negatively associated with FPG(r=-0.221)and TG(r=-0.250),and were negatively associated with NAFLD in all subjects(r=-0.111,P=0.009).The incidence of NAFLD tended to decrease as the 25(OH)D level increased.Conclusion The level of 25(OH)D was lower in the NAFLD group,and there is a close relationship between 25(OH)D and NAFLD.
作者 李玲 LI Ling(Department of Endocrinology,Shijingshan Teaching Hospital of Capital Medical University,Beijing Shijingshan Hospital,Beijing 100043 China)
出处 《内蒙古医学杂志》 2021年第7期776-779,共4页 Inner Mongolia Medical Journal
关键词 非酒精性脂肪肝 25羟维生素D 血糖 血脂 相关性 nonalcoholic fatty liver disease 25-Hydroxy Vitamin D blood glucose dyslipidemia correlation
  • 相关文献

参考文献2

二级参考文献49

  • 1Nobili V, Alkhouri N, Alisi A, Della Corte C, Fitzpatrick E, RaponiM, Dhawan A. Nonalcoholic fatty liver disease: a challenge for pediatricians. JAMA Pediatr 2015; 169: 170-176 [PMID: 25506780DOI: 10.1001/jamapediatrics.2014.2702].
  • 2Williams CD, Stengel J, Asike MI, Torres DM, Shaw J, ContrerasM, Landt CL, Harrison SA. Prevalence of nonalcoholic fatty liverdisease and nonalcoholic steatohepatitis among a largely middleagedpopulation utilizing ultrasound and liver biopsy: a prospectivestudy. Gastroenterology 2011; 140: 124-131 [PMID: 20858492DOI: 10.1053/j.gastro.2010.09.038].
  • 3Anstee QM, Targher G, Day CP. Progression of NAFLD todiabetes mellitus, cardiovascular disease or cirrhosis. Nat RevGastroenterol Hepatol 2013; 10: 330-344 [PMID: 23507799 DOI:10.1038/nrgastro.2013.41].
  • 4Vernon G, Baranova A, Younossi ZM. Systematic review: theepidemiology and natural history of non-alcoholic fatty liver diseaseand non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther2011; 34: 274-285 [PMID: 21623852 DOI: 10.1111/j.1365-2036.2011.04724.x].
  • 5Machado M, Marques-Vidal P, Cortez-Pinto H. Hepatic histologyin obese patients undergoing bariatric surgery. J Hepatol 2006; 45:600-606 [PMID: 16899321].
  • 6Gaggini M, Morelli M, Buzzigoli E, DeFronzo RA, Bugianesi E,Gastaldelli A. Non-alcoholic fatty liver disease (NAFLD) and itsconnection with insulin resistance, dyslipidemia, atherosclerosisand coronary heart disease. Nutrients 2013; 5: 1544-1560 [PMID:23666091 DOI: 10.3390/nu5051544].
  • 7Wong RJ, Aguilar M, Cheung R, Perumpail RB, Harrison SA,Younossi ZM, Ahmed A. Nonalcoholic steatohepatitis is the secondleading etiology of liver disease among adults awaiting livertransplantation in the United States. Gastroenterology 2015; 148:547-555 [PMID: 25461851 DOI: 10.1053/j.gastro.2014.11.039].
  • 8Chitturi S, Abeygunasekera S, Farrell GC, Holmes-Walker J, HuiJM, Fung C, Karim R, Lin R, Samarasinghe D, Liddle C, WeltmanM, George J. NASH and insulin resistance: Insulin hypersecretionand specific association with the insulin resistance syndrome.Hepatology 2002; 35: 373-379 [PMID: 11826411].
  • 9Oni ET, Agatston AS, Blaha MJ, Fialkow J, Cury R, Sposito A,Erbel R, Blankstein R, Feldman T, Al-Mallah MH, Santos RD,Budoff MJ, Nasir K. A systematic review: burden and severity ofsubclinical cardiovascular disease among those with nonalcoholicfatty liver; should we care- Atherosclerosis 2013; 230: 258-267[PMID: 24075754 DOI: 10.1016/j.atherosclerosis.2013.07.052].
  • 10Than NN, Newsome PN. A concise review of non-alcoholicfatty liver disease. Atherosclerosis 2015; 239: 192-202 [PMID:25617860 DOI: 10.1016/j.atherosclerosis.2015.01.001].

共引文献1782

同被引文献9

引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部